Literature DB >> 10900176

NF- kappa B independent suppression of endothelial vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 gene expression by inhibition of flavin binding proteins and superoxide production.

P E Tummala1, X L Chen, R M Medford.   

Abstract

Oxidation-reduction (redox) coupled mechanisms play an important role in the regulation of cell surface adhesion molecule expression. In endothelial cells membrane-bound NADH/NADPH oxidase is a significant source of intracellular superoxide (O(2)(-)) production. We explored the role of flavin containing proteins such as NADH/NADPH oxidase in the induction of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) gene expression in human aortic endothelial cells (HAECs) and human dermal microvascular endothelial cells (HMECs). Treatment of HAECs by tumor necrosis factor- alpha (TNF- alpha, 100 U/ml) for 1 h induced a 31% increase in O(2)(-)production within 5 min as determined by lucigenin chemiluminescence analysis of whole cells (n=4, P<0.05). Pretreatment with the NADH/NADPH oxidase inhibitor diphenylene iodonium (DPI, 40 microm) for 1 h inhibited O(2)(-)production. DPI also inhibited TNF and LPS-induced VCAM-1 and ICAM-1 cell surface expression and TNF- alpha, LPS, or IL-1 beta induced VCAM-1 and ICAM-1 mRNA accumulation. However, DPI did not inhibit TNF- alpha -induced activation of nuclear NF- kappa B-like binding activity in HAECs and HMECs. Furthermore, DPI did not inhibit TNF- alpha induced transactivation of NF- kappa B-driven VCAM-1 and HIV-LTR promoter gene constructs in transiently transfected HMECs. These data suggest that flavin binding proteins such as NADH/NADPH oxidase can regulate VCAM-1 gene expression independent of NF- kappa B. Furthermore, intracellular O(2)(-)generation is not necessary for NF- kappa B activation or for transactivation of NF- kappa B driven promoters. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900176     DOI: 10.1006/jmcc.2000.1183

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  5 in total

1.  Assessment of Novel Antioxidant Therapy in Atherosclerosis by Contrast Ultrasound Molecular Imaging.

Authors:  Tamara Atkinson; William Packwood; Aris Xie; Sherry Liang; Yue Qi; Zaverio Ruggeri; Jose Lopez; Brian P Davidson; Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2018-09-11       Impact factor: 5.251

2.  Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition.

Authors:  Yani Liu; Brian P Davidson; Qi Yue; Todd Belcik; Aris Xie; Yoichi Inaba; Owen J T McCarty; Garth W Tormoen; Yan Zhao; Zaverio M Ruggeri; Beat A Kaufmann; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2012-12-13       Impact factor: 7.792

Review 3.  Redox regulation of cell migration and adhesion.

Authors:  Thomas Ryan Hurd; Matthew DeGennaro; Ruth Lehmann
Journal:  Trends Cell Biol       Date:  2011-12-31       Impact factor: 20.808

4.  Annexin peptide Ac2-26 suppresses TNFα-induced inflammatory responses via inhibition of Rac1-dependent NADPH oxidase in human endothelial cells.

Authors:  Hitesh M Peshavariya; Caroline J Taylor; Celeste Goh; Guei-Sheung Liu; Fan Jiang; Elsa C Chan; Gregory J Dusting
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

Review 5.  Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase.

Authors:  James J DiNicolantonio; Mark McCarty
Journal:  Open Heart       Date:  2020-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.